{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:30:41Z","timestamp":1793403041779,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Female reproductive system diseases severely threaten women\u2019s health. This study aims to evaluate the disease burden caused by female reproductive system diseases from 1990 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We extracted female reproductive system disorder data from the Global Burden of Disease Study 2021. First, we assessed the global and subtype-specific incidence, prevalence, deaths, and disability-adjusted life years (DALYs) in 2021, reported as absolute numbers and age-standardized rates (ASIR, ASPR, ASDR, and AS-DALYs). Temporal trends from 1990 to 2021 were analyzed using linear regression models, with estimated annual percentage change quantifying burden trajectories. Finally, Bayesian hierarchical models were applied to project future disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, global gynecological disease burdens showed distinct patterns. Cervical cancer: 667\u00a0426 incident cases (ASIR 7.79) and 296\u00a0667 deaths (ASDR 3.44); ovarian cancer: 298\u00a0876 cases (ASIR 3.48) with 185\u00a0609 deaths (ASDR 2.16); uterine cancer: 473\u00a0614 cases (ASIR 5.41) resulting in 97\u00a0672 deaths (ASDR 1.14); uterine fibroids: prevalence dominated with 10.1 million cases (ASIR 124.22) but minimal mortality (2078 deaths; ASDR 0.02); female infertility: affected 110.1 million women with 601 134 DALYs. Temporal analysis (1990\u20132021) revealed rising absolute case numbers alongside stable\/declining ASRs for cervical and ovarian cancers. Disease burden peaked in middle-aged and older populations. Different diseases present distinct patterns of geographical distribution. Projections through 2045 forecast continued case count increases for malignancies and fibroids, with ASRs remaining stable for cervical cancer and infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study offers a comprehensive and updated evaluation of the global burden of female reproductive system diseases. The findings underscore the pressing need for targeted interventions and policies to address these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003558","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:10:12Z","timestamp":1759853412000},"page":"9166-9177","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Incidence, prevalence, deaths, and DALYs of diseases of the female reproductive system from 1990 to 2021 across 204 countries: data, with critical re-analysis, from the global burden of disease study"],"prefix":"10.1097","volume":"111","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Reproductive Medicine, Hebei Medical University Third Hospital, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Hou","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Social Medicine and Health Care Management, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, School of Public Health, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Experimental Center for Teaching, Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"R1-20261030","doi-asserted-by":"crossref","first-page":"4030\u201339","DOI":"10.1002\/cncr.33795","article-title":"Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years","volume":"127","author":"Lin","year":"2021","journal-title":"Cancer"},{"key":"R2-20261030","doi-asserted-by":"crossref","first-page":"426\u201327","DOI":"10.1136\/ijgc-2020-001285","article-title":"World Health Organization call for action to eliminate cervical cancer globally","volume":"30","author":"Gultekin","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R3-20261030","first-page":"7\u201330","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R4-20261030","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R5-20261030","doi-asserted-by":"crossref","first-page":"2607\u201318","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"key":"R6-20261030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41572-021-00324-8","article-title":"Endometrial cancer","volume":"7","author":"Makker","year":"2021","journal-title":"Nature Reviews Disease Primers"},{"key":"R7-20261030","doi-asserted-by":"crossref","first-page":"3\u20139","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20261030","first-page":"533\u201335","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"key":"R9-20261030","doi-asserted-by":"crossref","first-page":"140\u201362","DOI":"10.1111\/j.1467-9566.2009.01213.x","article-title":"The experience of infertility: a review of recent literature","volume":"32","author":"Greil","year":"2010","journal-title":"Sociol Health Illn"},{"key":"R10-20261030","first-page":"1789\u2013858","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R11-20261030","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence\u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R12-20261030","first-page":"1423\u201359","article-title":"Measuring progress and projecting attainment on the basis of past trends of the health-related sustainable development goals in 188 countries: an analysis from the global burden of disease study 2016","volume":"390","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"key":"R13-20261030","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R15-20261030","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"R16-20261030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12905-021-01571-3","article-title":"Global, regional, and national burden of cervical cancer for 195 countries and territories, 2007-2017: findings from the global burden of disease study 2017","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Womens Health"},{"key":"R17-20261030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jama.2020.25214","article-title":"Cervical cancer screening in low- and middle-income countries","volume":"325","author":"Cremer","year":"2021","journal-title":"Jama"},{"key":"R18-20261030","first-page":"17\u201348","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R19-20261030","first-page":"209\u201349","article-title":"Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R20-20261030","doi-asserted-by":"crossref","first-page":"89\u2013105","DOI":"10.1080\/15384047.2020.1868937","article-title":"Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease","volume":"22","author":"Arend","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"R21-20261030","doi-asserted-by":"crossref","first-page":"6\u20138","DOI":"10.1038\/s43018-020-00166-5","article-title":"Advances in ovarian cancer, from biology to treatment","volume":"2","author":"McMullen","year":"2021","journal-title":"Nat Cancer"},{"key":"R22-20261030","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/cancers13112623","article-title":"New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP Guidelines","volume":"13","author":"Santoro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R23-20261030","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/cancers13092149","article-title":"A narrative review of the role of diet and lifestyle factors in the development and prevention of endometrial cancer","volume":"13","author":"Yasin","year":"2021","journal-title":"Cancers"},{"key":"R24-20261030","doi-asserted-by":"crossref","first-page":"705\u201315","DOI":"10.1007\/s00394-012-0376-7","article-title":"Glycemic index, glycemic load and endometrial cancer risk: results from the Australian national endometrial cancer study and an updated systematic review and meta-analysis","volume":"52","author":"Nagle","year":"2013","journal-title":"Eur J Nutr"},{"key":"R25-20261030","doi-asserted-by":"crossref","first-page":"e0325907","DOI":"10.1371\/journal.pone.0325907","article-title":"Time since last birth and the risk of endometrial cancer: a meta-analysis of observational studies","volume":"20","author":"Gu","year":"2025","journal-title":"PLoS One"},{"key":"R26-20261030","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/IGC.0000000000000205","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma","volume":"24","author":"Amant","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R27-20261030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"R28-20261030","first-page":"1859\u2013922","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators Gda","year":"2018","journal-title":"Lancet"},{"key":"R29-20261030","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys","volume":"9","author":"Mascarenhas","year":"2012","journal-title":"PLoS Med"},{"key":"R30-20261030","doi-asserted-by":"crossref","first-page":"411\u201326","DOI":"10.1093\/humupd\/dmv016","article-title":"Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century","volume":"21","author":"Inhorn","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R31-20261030","doi-asserted-by":"crossref","first-page":"605\u201321","DOI":"10.1093\/humupd\/dmn042","article-title":"Infertility and the provision of infertility medical services in developing countries","volume":"14","author":"Ombelet","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R32-20261030","doi-asserted-by":"crossref","first-page":"825\u201333","DOI":"10.1158\/1055-9965.EPI-22-0674","article-title":"Trend in cervical cancer incidence and mortality rates in china, 2006-2030: a bayesian age-period-cohort modeling study","volume":"32","author":"Yuan","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R33-20261030","first-page":"7\u201333","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:01:07Z","timestamp":1793401267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000003558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003558","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"2025-06-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}